Cytogenetic and molecular testing have become increasingly important in the diagnosis and classification and include identifying predisposing somatic mutations and karyotype abnormalities and revealing a distinct mutational landscape of childhood MDS involving somatic mutations in SETBP1, ASXL1, RUNX1, and the RAS pathway [5,11]. Here, RUNX1 is linked to myelodysplastic syndrome.